When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network.
The federal government has allocated more than $9 billion to develop and manufacture candidate vaccines. More than $2.5 billion more has been earmarked for vials to store the vaccines, syringes to deliver them, and on efforts to ramp up manufacturing and capacity.
And they're not done yet.
So far, the largest sums have gone to pharmaceutical giants Pfizer, AstraZeneca, and a collaboration between Sanofi and GSK, as well as biotech firms Moderna and Novavax – all of which have candidate vaccines being tested in people.
To save time in the development process, the companies have been running trials simultaneously that they usually run in sequence.
Moderna, for instance, hasn't yet published its phase 2 trial results, but is already in larger-scale phase 3 trials, beginning tests last week of its candidate vaccine in 15,000 volunteers. Phase 3 trials started this summer are expected to return results this fall, with the timing depending on how quickly they can find volunteers.
Rezvani's Latest Post-Apocalyptic Monster Is a Ford F-150 Raptor Underneath
Slideshow: Called the Fortress, the 850-horsepower pickup combines Raptor underpinnings with military-inspired features, survival equipment, and a starting price of $285,000.